Sidley represented Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, in connection with an approximately US$365.8 million combined primary and secondary underwritten public offering of its common stock by Outset and certain selling stockholders, which resulted in approximately US$149.7 million of proceeds to Outset, after deducting the underwriting discounts and commissions and before expenses.
Morgan Stanley, BofA Securities, and Goldman Sachs & Co. LLC acted as joint lead book-running managers for the offering. Stifel and Cowen acted as co-managers for the offering.
The Sidley team was led by Global Life Sciences partner Frank Rahmani (Palo Alto and San Francisco) and Capital Markets partner Robert Ryan (New York), and associates Helen Theung (Palo Alto), Nick DeAngelis (Dallas and Palo Alto), and Peiyu Yu (Palo Alto).
